Amanote Research
Register
Sign In
In Vitro Activity of HSR-903, a New Quinolone.
Antimicrobial Agents and Chemotherapy
- United States
doi 10.1128/aac.41.6.1326
Full Text
Open PDF
Abstract
Available in
full text
Categories
Infectious Diseases
Pharmacology
Date
June 1, 1997
Authors
Y Takahashi
N Masuda
M Otsuki
M Miki
T Nishino
Publisher
American Society for Microbiology
Related search
Comparative in Vitro Activity of a New Quinolone, AM-1091.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro and in Vivo Activity of NY-198, a New Difluorinated Quinolone.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of Sparfloxacin (AT-4140), a New Quinolone Agent, Against Invasive Isolates From Pediatric Patients.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro and in Vivo Antibacterial Activities of CS-940, a New 6-Fluoro-8-Difluoromethoxy Quinolone.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Hypersensitivity Reaction (HSR) to Docetaxel After a Previous HSR to Paclitaxel
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
In Vitro Activity of BAY 12-8039, a New Fluoroquinolone.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro ACTIVITY OF BL-S217, a NEW CEPHALOSPORIN ANTIBIOTIC
Journal of Antibiotics
Drug Discovery
Pharmacology
In Vitro Activity of Ciprofloxacin, a New Carboxyquinoline Antimicrobial Agent.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of BMS-181139, a New Carbapenem With Potent Antipseudomonal Activity
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology